Literature DB >> 10479144

Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.

S Kastenbauer1, U Koedel, H W Pfister.   

Abstract

This study investigated the role of peroxynitrite in an adult rat model of pneumococcal meningitis. Immunohistochemically, nitrotyrosine residues, as a marker for peroxynitrite formation, were detected perivascularly and in proximity to inflammatory cells in the subarachnoid space. Nitrotyrosine immunoreactivity was colocalized with blood-brain barrier breaching, which was visualized by fluorescence microscopy after intravenous application of Evans blue. Treatment of infected rats with uric acid (300 mg/kg intraperitoneally), a scavenger of peroxynitrite, significantly attenuated intracranial pressure, cerebrospinal fluid white blood cell count, and blood-brain barrier leakage, as indicated by Evans blue concentration in the cerebrospinal fluid (21.6+/-9.3 mm Hg, 5776+/-1790 cells/microL, 9.7+/-6.4 microgram/mL in infected, untreated rats vs. 7.2+/-1.6 mm Hg, 2004+/-904 cells/microL, 1.1+/-1.0 microgram/mL infected, uric acid-treated rats, mean+/-SD, P<.05). These data suggest that peroxynitrite plays a central role in mediating pathophysiological alterations during bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479144     DOI: 10.1086/315048

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  New Advances in the Pathogenesis and Pathophysiology of Bacterial Meningitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

Review 2.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 3.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Prognostic significance of serum antioxidant parameters in immunocompetent patients with cryptococcal meningitis.

Authors:  Y Liu; Y Jiang; A Wu; S Chen; Y Zhang; M Liu; X Ma; L Ma; X Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-06       Impact factor: 3.267

Review 5.  Streptococcus pneumoniae: Invasion and Inflammation.

Authors:  Allister J Loughran; Carlos J Orihuela; Elaine I Tuomanen
Journal:  Microbiol Spectr       Date:  2019-03

Review 6.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Serum uric acid levels and neuromyelitis optica.

Authors:  Fuhua Peng; Xiufeng Zhong; Xuhui Deng; Wei Qiu; Aimin Wu; Youming Long; Xueqiang Hu; Qing Li; Ying Jiang; Yongqiang Dai
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

8.  Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Authors:  K E Zucker; P Kamberi; R A Sobel; G Cloud; D N Meli; K V Clemons; D A Stevens; P L Williams; S L Leib
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

9.  Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis.

Authors:  Tobias Högen; Cornelia Demel; Armin Giese; Barbara Angele; Hans-Walter Pfister; Uwe Koedel; Matthias Klein
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

10.  Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis.

Authors:  Manuela Schaper; Stephen L Leib; Damian N Meli; Ralf P Brandes; Martin G Täuber; Stephan Christen
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.